These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 25847979)

  • 21. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
    Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ten-year Outcomes After Drug-Eluting Stents or Bypass Surgery for Left Main Coronary Disease in Patients With and Without Diabetes Mellitus: The PRECOMBAT Extended Follow-Up Study.
    Jeong YJ; Ahn JM; Hyun J; Lee J; Kim JH; Yang Y; Choe K; Park H; Kang DY; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park SJ; Park DW
    J Am Heart Assoc; 2021 Jul; 10(14):e019834. PubMed ID: 34238026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.
    Chen SL; Chen JP; Mintz G; Xu B; Kan J; Ye F; Zhang J; Sun X; Xu Y; Jiang Q; Zhang A; Stone GW
    JACC Cardiovasc Interv; 2010 Jun; 3(6):632-41. PubMed ID: 20630456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Patient-Reported Preprocedural Physical and Mental Health on 10-Year Mortality After Percutaneous or Surgical Coronary Revascularization.
    Ono M; Serruys PW; Garg S; Kawashima H; Gao C; Hara H; Lunardi M; Wang R; O'Leary N; Wykrzykowska JJ; Piek JJ; Mack MJ; Holmes DR; Morice MC; Kappetein AP; Thuijs DJFM; Noack T; Mohr FW; Davierwala PM; Spertus JA; Cohen DJ; Onuma Y;
    Circulation; 2022 Oct; 146(17):1268-1280. PubMed ID: 35862109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contemporary Outcomes Following Coronary Artery Bypass Graft Surgery for Left Main Disease.
    Modolo R; Chichareon P; Kogame N; Dressler O; Crowley A; Ben-Yehuda O; Puskas J; Banning A; Taggart DP; Kappetein AP; Sabik JA; Onuma Y; Stone GW; Serruys PW
    J Am Coll Cardiol; 2019 Apr; 73(15):1877-1886. PubMed ID: 30999989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease.
    Abdallah MS; Wang K; Magnuson EA; Osnabrugge RL; Kappetein AP; Morice MC; Mohr FA; Serruys PW; Cohen DJ;
    J Am Coll Cardiol; 2017 Apr; 69(16):2039-2050. PubMed ID: 28427580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
    Ben-Yehuda O; Chen S; Redfors B; McAndrew T; Crowley A; Kosmidou I; Kandzari DE; Puskas JD; Morice MC; Taggart DP; Leon MB; Lembo NJ; Brown WM; Simonton CA; Dressler O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Eur Heart J; 2019 Jun; 40(24):1930-1941. PubMed ID: 30919909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 32. C-reactive protein and prognosis after percutaneous coronary intervention and bypass graft surgery for left main coronary artery disease: Analysis from the EXCEL trial.
    Kosmidou I; Redfors B; Chen S; Crowley A; Lembo NJ; Karmpaliotis D; Brown WM; Maupas E; Durrleman N; Shah A; Reardon MJ; Dressler O; Ben-Yehuda O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Am Heart J; 2019 Apr; 210():49-57. PubMed ID: 30738244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of SYNTAX Score on 10-Year Outcomes After Revascularization for Left Main Coronary Artery Disease.
    Yoon YH; Ahn JM; Kang DY; Park H; Cho SC; Lee PH; Lee SW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2020 Feb; 13(3):361-371. PubMed ID: 32029254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL Trial.
    Diamond J; Madhavan MV; Sabik JF; Serruys PW; Kappetein AP; Leon MB; Taggart DP; Berland J; Morice MC; Gersh BJ; Kandzari DE; Dressler O; Stone GW
    JACC Cardiovasc Interv; 2018 Dec; 11(24):2441-2450. PubMed ID: 30573053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Diabetic Status on Outcomes After Revascularization With Drug-Eluting Stents in Relation to Coronary Artery Disease Complexity: Patient-Level Pooled Analysis of 6081 Patients.
    Koskinas KC; Siontis GC; Piccolo R; Franzone A; Haynes A; Rat-Wirtzler J; Silber S; Serruys PW; Pilgrim T; Räber L; Heg D; Jüni P; Windecker S
    Circ Cardiovasc Interv; 2016 Feb; 9(2):e003255. PubMed ID: 26823484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial.
    Morice MC; Serruys PW; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Torracca L; van Es GA; Leadley K; Dawkins KD; Mohr F
    Circulation; 2010 Jun; 121(24):2645-53. PubMed ID: 20530001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease.
    Mack MJ; Head SJ; Holmes DR; Ståhle E; Feldman TE; Colombo A; Morice MC; Unger F; Erglis A; Stoler R; Dawkins KD; Serruys PW; Mohr FW; Kappetein AP
    JACC Cardiovasc Interv; 2013 Apr; 6(4):344-54. PubMed ID: 23523456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2).
    Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Tazaki J; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    Am J Cardiol; 2015 Jul; 116(1):59-65. PubMed ID: 25956622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery Occlusions.
    Kawashima H; Takahashi K; Ono M; Hara H; Wang R; Gao C; Sharif F; Mack MJ; Holmes DR; Morice MC; Head SJ; Kappetein AP; Thuijs DJFM; Milojevic M; Noack T; Mohr FW; Davierwala PM; Serruys PW; Onuma Y;
    J Am Coll Cardiol; 2021 Feb; 77(5):529-540. PubMed ID: 33538250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.
    Mancini GBJ; Boden WE; Brooks MM; Vlachos H; Chaitman BR; Frye R; Bittner V; Hartigan PM; Dagenais GR
    Atherosclerosis; 2018 Oct; 277():186-194. PubMed ID: 29861270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.